融創中國(1918.HK)大漲超11% 業績超預期 “三道紅線”降至黃檔
格隆匯3月12日丨融創中國(1918.HK)盤中持續走高,一度大漲超11%報33.7港元,帶動港股市場內房股集體走強,寶龍地產、SOHO中國、綠城中國等均明顯上漲。融創今早公佈業績顯示,2020年營收2305.9億元,同比增36.2%;歸母淨利潤356.4億元,同比增36.9%;核心淨利潤302.6億元,同比增11.8%;截至2020年底,融創在手現金1326億元。報吿顯示,2020年融創淨負債率與非受限制現金短債比成功達到“三道紅線”政策標準,公司已連降兩檔至“黃檔”,降槓桿速度遠超市場預期。經過2020年的努力,融創地產主業發展越來越均衡,“地產+”呈現出勃勃生機,展現出強勢發展的苗頭。業績發佈後,花旗給予其買入評級,目標價46.8港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.